Suchergebnisse - "Guzauskas, Gregory F"

PubPharm (28)

1

Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment

enthalten in: PharmacoEconomics | 2019

von Kim, D. | Guzauskas, G. | Bennette, C. | +4

2

Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment

enthalten in: PharmacoEconomics | 2019

von Kim, D. | Guzauskas, G. | Bennette, C. | +4

3

Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment

enthalten in: PharmacoEconomics | 2019

von Kim, D. | Guzauskas, G. | Bennette, C. | +4

4

Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma : a cost-effectiveness study

enthalten in: Journal of medical economics | 2019

von Guzauskas, G. | Pollom, E. | Stieber, V. | +2

5

Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2019

von Guzauskas, G. | Basu, A. | Carlson, J. | +1

6

Obinutuzumab plus chemotherapy followed by obinutuzumab monotherapy is cost-effective vs. rituximab plus chemotherapy followed by rituximab monotherapy for previously untreated follicular lymphoma patients in the United States

enthalten in: Leukemia & lymphoma | 2019

von Guzauskas, G. | Masaquel, A. | Thuresson, P. | +2

7

Cost-effectiveness of obinutuzumab plus bendamustine followed by obinutuzumab monotherapy for the treatment of follicular lymphoma patients who relapse after or are refractory to a rituximab-containing regimen in the US

enthalten in: Journal of medical economics | 2018

von Guzauskas, G. | Masaquel, A. | Reyes, C. | +3

8

Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization : A pilot study

enthalten in: Cancer medicine | 2018

von Carlson, J. | Kim, D. | Guzauskas, G. | +7

9

The Authors Respond : Reframing the Value of Treatments for Relapsed Refractory Multiple Myeloma

enthalten in: Journal of managed care & specialty pharmacy | 2018

von Carlson, J. | Guzauskas, G. | Chapman, R. | +6

CommentOn: J Manag Care Spec Pharm. 2018 Jan;24(1):29-38. - PMID 29290170

10

Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients

enthalten in: CNS oncology | 2018

von Guzauskas, G. | Salzberg, M. | Wang, B.